by National Comprehensive Cancer Network Credit: Pixabay/CC0 Public Domain New research in the May 2023 issue of the Journal of the National Comprehensive Cancer Network from Moffitt Cancer Center finds that telemedicine consistently outperformed in-person visits for both access to care and provider response, according to a long-term study on patient experience. Researchers analyzed survey responses from 39,268 patients across...
AMERICAN SOCIETY FOR RADIATION ONCOLOGY ARLINGTON, Va., February 27, 2023 — A new study finds that recent increases in Medicare spending on outpatient cancer care at the end of patients’ lives were driven almost entirely by a type of treatment given to fewer than 1 in 5 patients. The study is published in the International Journal of Radiation...
Leonard L. Berry, University Distinguished Professor of Marketing, Mays Business School; Senior Fellow, Institute for Healthcare Improvement, Texas A&M University Sun, November 20, 2022 at 7:05 AM·6 min read In this Dec. 3, 2014 photo, liver cancer patient Crispin Lopez Serrano talks to an oncology nurse at a hospital in Clackamas, Ore. Cancer may...
Roxanne Nelson, RN, BSN June 09, 2022 A new analysis shows that the United States spends twice as much on cancer care as the average high-income country, but its cancer mortality rates are only slightly better than average. “The US is spending over $200 billion per year on cancer care — roughly $600 per person,...
by Karen Astle, American Heart Association One in six people with broken heart syndrome had cancer and they were less likely to survive for five years after it occurred, according to new international research in Journal of the American Heart Association. Broken heart syndrome, also called takotsubosyndrome, occurs when the heart’s main pumping chamber temporarily enlarges and doesn’t pump well. Although the syndrome may feel like a heart attack, with...
Tel Aviv University, Harvard University researchers discuss the untapped potential of targeted nanocarriers to revolutionize cancer therapy A new Tel Aviv University study addresses the challenges of nanoparticle-based cancer-targeting strategies. It also suggests ways of refocusing the collaborative work of cancer researchers and clinicians to move the field forward from “the bench” to the patients....
